Trans-Atlantic Business Dialogue is potential ombudsman for MRA -- former ITC chair testifies.
TABD FOCUS ON DATA PROTECTION IS POSSIBLE AGENDA ITEM likely to emerge for the Transatlantic Business Dialogue following a meeting of the organization in early November, Warner-Lambert CEO Lodewijk de Vink indicated at a hearing before the House Ways & Means/Trade Subcommittee July 23. While it is "premature to discuss a `future agenda' of the TABD," de Vink said, "certain issues deserve mention."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth